Changhang Lin, Jinjin Li, Chen Su, Shuwen Xiong, Xiaorui Kang, Junwen Lu and Leyi Wei*,
{"title":"LysePred: A Multiscale Convolutional Neural Network for Predicting Hemolytic Activity of Antimicrobial Peptides","authors":"Changhang Lin, Jinjin Li, Chen Su, Shuwen Xiong, Xiaorui Kang, Junwen Lu and Leyi Wei*, ","doi":"10.1021/acssynbio.6c00173","DOIUrl":null,"url":null,"abstract":"<p >Antimicrobial peptides (AMPs) represent promising alternatives to conventional antibiotics, yet hemolytic toxicity remains a critical barrier to clinical translation, with approximately 70% of known AMPs exhibiting high or moderate hemolytic activity. Existing computational prediction methods are often constrained by deficiencies, including high computational complexities, the inability to capture multiscale sequence patterns, and insufficient generalization across diverse datasets. We present LysePred, a multiscale convolutional neural network to address these deficiencies concurrently by employing parallel branches with exponentially spaced kernel sizes to simultaneously capture local amino acid motifs (bigrams, 4-g) and longer-range amphipathic patterns (8- to 32-g). LysePred achieves top-tier performance on six benchmark datasets, exceeding the performance of the second-best method by 9.13% in MCC and 3.65% in ACC on average, while maintaining exceptional stability (MCC CV < 6.92%, ACC CV < 2.73%). Furthermore, independent validation on the HemoPI2 dataset demonstrates that LysePred delivers highly competitive results with a computationally parsimonious design (∼0.55 M parameters). This represents a reduction in parameter density of 1 to 2 orders of magnitude compared to Transformer-based approaches, such as the 8M-parameter ESM-2 or the 110M-parameter BERT Base while maintaining linear complexity for high-throughput screening. Ablation studies validate that the multiscale architecture contributes meaningfully to performance, with single-scale variants showing up to 13.35% MCC degradation. Interpretability analyses via t-SNE visualization and SHAP feature importance reveal that LysePred learns biologically meaningful representations integrating both local sequence motifs and global structural patterns. LysePred offers a practical, efficient, and interpretable tool for rapid hemolytic toxicity prediction in antimicrobial peptide development. Code and data are available at https://github.com/lincubator/LysePred.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"15 7","pages":"3017–3030"},"PeriodicalIF":4.5000,"publicationDate":"2026-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Synthetic Biology","FirstCategoryId":"99","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acssynbio.6c00173","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Antimicrobial peptides (AMPs) represent promising alternatives to conventional antibiotics, yet hemolytic toxicity remains a critical barrier to clinical translation, with approximately 70% of known AMPs exhibiting high or moderate hemolytic activity. Existing computational prediction methods are often constrained by deficiencies, including high computational complexities, the inability to capture multiscale sequence patterns, and insufficient generalization across diverse datasets. We present LysePred, a multiscale convolutional neural network to address these deficiencies concurrently by employing parallel branches with exponentially spaced kernel sizes to simultaneously capture local amino acid motifs (bigrams, 4-g) and longer-range amphipathic patterns (8- to 32-g). LysePred achieves top-tier performance on six benchmark datasets, exceeding the performance of the second-best method by 9.13% in MCC and 3.65% in ACC on average, while maintaining exceptional stability (MCC CV < 6.92%, ACC CV < 2.73%). Furthermore, independent validation on the HemoPI2 dataset demonstrates that LysePred delivers highly competitive results with a computationally parsimonious design (∼0.55 M parameters). This represents a reduction in parameter density of 1 to 2 orders of magnitude compared to Transformer-based approaches, such as the 8M-parameter ESM-2 or the 110M-parameter BERT Base while maintaining linear complexity for high-throughput screening. Ablation studies validate that the multiscale architecture contributes meaningfully to performance, with single-scale variants showing up to 13.35% MCC degradation. Interpretability analyses via t-SNE visualization and SHAP feature importance reveal that LysePred learns biologically meaningful representations integrating both local sequence motifs and global structural patterns. LysePred offers a practical, efficient, and interpretable tool for rapid hemolytic toxicity prediction in antimicrobial peptide development. Code and data are available at https://github.com/lincubator/LysePred.
期刊介绍:
The journal is particularly interested in studies on the design and synthesis of new genetic circuits and gene products; computational methods in the design of systems; and integrative applied approaches to understanding disease and metabolism.
Topics may include, but are not limited to:
Design and optimization of genetic systems
Genetic circuit design and their principles for their organization into programs
Computational methods to aid the design of genetic systems
Experimental methods to quantify genetic parts, circuits, and metabolic fluxes
Genetic parts libraries: their creation, analysis, and ontological representation
Protein engineering including computational design
Metabolic engineering and cellular manufacturing, including biomass conversion
Natural product access, engineering, and production
Creative and innovative applications of cellular programming
Medical applications, tissue engineering, and the programming of therapeutic cells
Minimal cell design and construction
Genomics and genome replacement strategies
Viral engineering
Automated and robotic assembly platforms for synthetic biology
DNA synthesis methodologies
Metagenomics and synthetic metagenomic analysis
Bioinformatics applied to gene discovery, chemoinformatics, and pathway construction
Gene optimization
Methods for genome-scale measurements of transcription and metabolomics
Systems biology and methods to integrate multiple data sources
in vitro and cell-free synthetic biology and molecular programming
Nucleic acid engineering.